Analysis of Artificial Tear Eye Drops For Elemental Impurities

Application Note Pharmaceuticals Validating performance of an Agilent ICP‑MS for USP <232>/<233> & ICH Q3D(R2)/Q2(R1) Reducing the time and expense of ICP-MS method development and system validation for measuring elemental impurities in pharmaceuticals Authors Lindsey Whitecotton, Ed McCurdy, Craig Jones…

Application Note Biopharma Analysis of Elemental Impurities in Synthetic Oligonucleotides by ICP-MS Development and testing of an efficient Agilent 7850 ICP-MS method in compliance with USP <232>/<233> and ICH Q3D(R2)/Q2(R1) Authors Introduction Bian Yulan and Li Shuping Synthetic oligonucleotides are…

Application Note BioPharma Analysis of Elemental Impurities in GLP-1 Receptor Agonist Oral Tablets by ICP-MS Evaluation of an Agilent 7850 ICP-MS method compliant with USP <232>/<233> and ICH Q3D(R2)/ Q2(R2) Authors Bian Yulan and Li Shuping, Agilent Technologies, Inc. Introduction…

APPLICATION NOTE 44385 Analysis of elemental impurities in drug products using the Thermo Scientific iCAP 7400 ICP-OES Duo Authors Introduction Sanja Asendorf, Application Specialist, Thermo Fisher Scientific, Bremen, Germany Impurities in pharmaceutical products are of great concern not only due…